A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant
administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular
hypertension.